Elevated Steady State WBC and Platelet Counts Are Associated with Frequent Emergency Room Use in Adults with Sickle Cell Anemia
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Sickle cell anemia has many sequelae that result in emergency department (ED) use, but a minority of patients with sickle cell disease are frequent utilizers and make up the majority of ED visits. If patients who are likely to be frequent ED can be identified in steady state, they can be treated with disease modifying agents in an attempt to reduce ED use frequency. We sought to identify steady state markers for frequent ED use. METHODS: We identified all patients with SS/Sβ0 seen at our facilities in 2012. Health care utilization over the entire year was calculated and ED visit numbers categorized as either 0-1, 2-5, or 6 or more visits a year. Steady state and acutely active laboratory parameters were collected and analyzed using analysis of variance models and odds ratios. RESULTS: 432 adult sickle cell patients were identified, ages 18-87, 54% female, and 38% had been prescribed hydroxyurea. Of the 432 patients,192 had 0-1 visits in the year, 144 had 2-5 visits in the year, and 96 had >6 visits for a total of 2259 visits. Those who had >6 visits accounted for 1750 (77%) of the total visits for the year. When steady state laboratory markers were examined, each additional 50x10(9)/L platelets was associated with 22% greater risk (p < .001); each 1x10(9)/L of WBC was associated with 11% greater risk (p = .003), and each 1g/dL Hb was associated with 23% lower risk (p = .007) of >6 ED visits/year. We did not observe a relationship between baseline HbF, LDH or reticulocyte count with >6 ED visits. CONCLUSION: Patients with elevated white blood cell counts, elevated platelet counts, and low hemoglobin levels exhibited higher risk for frequent ED utilization and could be candidates for early and aggressive therapy with disease modifying agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, SCD patients are known to have elevated levels of neutrophils, monocytes and platelets at baseline, and elevated levels of circulating neutrophil-platelet and monocyte-platelet aggregates in SCD human blood correlate with disease severity (19–28).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340 · cited 3×
“Hydroxyurea has been shown to reduce levels of white blood cells, platelets, and intracellular adhesion molecules and to result in fewer episodes of pain crisis as well as lower overall emergency room utilization.[10,11,26,27] Previous studies have shown that frequent ED utilizers are more likely to be prescribed hydr…”
BackgroundKato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Daily Assessment of Pain in Adults with Sickle Cell Disease
Smith, W. R., Penberthy, L. T., Bovbjerg, V. E., McClish, D. K., Roberts, J. D., Dahman, B., Aisiku, I. P., Levenson, J. L., & Roseff, S. D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00004 · Cited by 648
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up
Steinberg, M. H., McCarthy, W. F., Castro, O., Ballas, S. K., Armstrong, F. D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21699 · Cited by 486 · cited 2×
“[11] The cohort prescribed hydroxyurea had significantly higher MCVs than the cohort not prescribed hydroxyurea Table 2.”
Epidemiologic Analysis of an Urban, Public Emergency Department's Frequent Users
Mandelberg, J. H., Kuhn, R. E., & Kohn, M. A. (2000) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2000.tb02037.x · Cited by 362 · cited 1×
“[9,13,14] It has been shown that it is difficult to identify objective parameters for sickle cell crisis, although there is some evidence for an association of crisis with increasing LDH levels and a decrease in dense cells, as demonstrated by decreasing RDW, indirect bilirubin and MCV.”
BackgroundFactors associated with survival in a contemporary adult sickle cell disease cohort
Elmariah, H., Garrett, M. E., De Castro, L. M., Jonassaint, J. C., Ataga, K. I., Eckman, J. R., Ashley‐Koch, A. E., & Telen, M. J. (2014) · American Journal of Hematology · doi:10.1002/ajh.23683 · Cited by 300
Brawley, O. W., Cornelius, L. J., Edwards, L. R., Gamble, V. N., Green, B. L., Inturrisi, C., James, A. H., Laraque, D., Mendez, M., Montoya, C. J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00220 · Cited by 272 · cited 1×
“[4,28] Another possibility is that these may represent “nonresponders” since the MCV and the WBC did behave in a hydroxyurea-appropriate manner.”
BackgroundEvidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014
National Heart, L. (2017) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020862-part06-evidence_based · Cited by 255
Red blood cell changes during the evolution of the sickle cell painful crisis
Ballas, S., & Smith, E. (1992) · Blood · doi:10.1182/blood.v79.8.2154.2154 · Cited by 250
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli
Bennewitz, M. F., Jimenez, M. A., Vats, R., Tutuncuoglu, E., Jonassaint, J., Kato, G. J., Gladwin, M. T., & Sundd, P. (2017) · JCI Insight · doi:10.1172/jci.insight.89761 · Cited by 139
“SCD patients experience leukocytosis even under a steady-state condition (11, 12, 43), and therefore, interference with neutrophil recruitment can cause an elevation in cir-”
BackgroundLeonard, A. K., Sharma, A., Uchida, N., Stroncek, D. F., Panch, S. R., West, K. A., Molloy, E., Hughes, T. E., Hauffe, S., Taylor, T. N., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004232 · Cited by 61
“Overtime, the recurrent use of hospital services to manage disease complications is associated with adverse clinical outcomes including early mortality.(32-43) In this study, individuals with greater hospitalization frequency within the previous year in addition to individuals on multiple medications for chronic pain…”
BackgroundLee, S., Vania, D. K., Bhor, M., Revicki, D. A., Abògúnr̀in, Ṣ., & Sarri, G. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s257340 · Cited by 50
Ofakunrin, A. O. D., Oguche, S., Adekola, K., Okpe, E. S., Afolaranmi, T., Diaku-Akinwumi, I., Zoakah, A., & Sagay, A. S. (2019) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmz070 · Cited by 47
“Elevated steady state leucocyte and platelet counts have been documented to be recognized triggers for the vaso-occlusive events occurring in SCA [30].”
BackgroundAhmed, A. E., Ali, Y. Z., AlSuliman, A. M., Albagshi, J. M., Salamah, M. A., Elsayid, M., Alenezi, W., Ahmed, R. A., McClish, D. K., & Al-Jahdali, H. H. (2017) · Journal of Blood Medicine · doi:10.2147/jbm.s148463 · Cited by 32
“Evidence was found that a high level of WBC count is recognized as a major risk factor for hospital admission and frequent ED visits.(15,16) Olatunji and Davies(15) documented that patients with particularly high levels of WBCs had frequent hospital admission.”
BackgroundNader, É., Garnier, Y., Connes, P., & Romana, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.728693 · Cited by 25
Curtis, S. A., Brandow, A. M., DeVeaux, M., Zeltermam, D., Devine, L., & Roberts, J. D. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0036 · Cited by 34
“some cross-sectional studies of adults with SCD that show hydroxyurea use correlated with poor outcomes.(20) Disease severity is associated with likelihood of using hydroxyurea and with likelihood of poor outcomes so disease severity is a confounder for the effect”
BackgroundSelf-citationZiemba, Y. C., Xu, C., Fomani, K., Nandi, V., Yuan, T., Rehmani, S., Sachais, B. S., Appiah‐Kubi, A., Aygün, B., Louie, J. E., et al. (2020) · Transfusion · doi:10.1111/trf.16225 · Cited by 23
Kidwell, K. M., Albo, C., Pope, M., Bowman, L., Xu, H., Wells, L., Barrett, N. J., Patel, N., Allison, A., & Kutlar, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247324 · Cited by 22
Meher, S., Patel, S., Das, K., Dehury, S., Jit, B. P., Maske, M. M., Das, P., Dash, B. P., & Mohanty, P. K. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03776-x · Cited by 23
Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in sickle cell disease
Jimenez, M. A., Novelli, E. M., Shaw, G. D., & Sundd, P. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017006742 · Cited by 20
Meher, S., Mohanty, P. K., Patel, S., Das, K., Sahoo, S., Dehury, S., Mohapatra, M. K., Jit, B. P., Das, P., & Dash, B. P. (2021) · Hemoglobin · doi:10.1080/03630269.2020.1801459 · Cited by 18
Ugwu, A. O. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/26446.10042 · Cited by 17
Ballas, S. K., & Dampier, C. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04205-0 · Cited by 16
“These values were linearly and statistically significantly associated with ED utilization [26].”
BackgroundInfluentialImpact of Abnormal Leukocyte Count in the Pathophysiology of Sickle Cell Anemia
Yousif, T. Y. E. (2022) · Journal of Blood Medicine · doi:10.2147/jbm.s378133 · Cited by 23
“First, there is a ton of evidence that leukocytes play a part in the development of SCD. Adults with SCD and elevated white cell counts were more likely to visit the Emergency Department (ED) as a result of sickle cell crises, according to Curtis et al.4 Leukocytes, like erythrocytes, may aid in SCD vaso-occlusion by…”
BackgroundJit, B. P., Mohanty, P. K., Purohit, P., Das, K., Patel, S., Meher, S., Mohanty, J. R., Sinha, S., Behera, R. K., & Das, P. (2018) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2018.12.003 · Cited by 16
Najjar, S. A., Adam, S. S., Ahmed, N., & Qari, M. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2823-7 · Cited by 14
“The role of leucocytes in the pathophysiology of SCD is described as pivotal, and an increase in leucocyte count is associated with mortality, acute chest syndrome, and VOC [10, 4, 11, 12].”
BackgroundReduced peripheral blood superoxide dismutase 2 expression in sickle cell disease
Armenis, I., Kalotychou, V., Tzanetea, R., Moyssakis, I. E., Anastasopoulou, D., Pantos, C., Konstantopoulos, K., & Rombos, I. (2019) · Annals of Hematology · doi:10.1007/s00277-019-03709-8 · Cited by 14
Awoda, S., Daak, A. A., Husain, N. E., Ghebremeskel, K., & Elbashir, M. I. (2017) · BMC Hematology · doi:10.1186/s12878-017-0089-5 · Cited by 12
“Consistent with previous studies, both the omega-3 fatty acid treated and untreated patients had elevated steady state white blood cell and platelet counts confirming that sickle cell disease is a chronic inflammatory disorder [22].”
ResultInvestigation of Lipid Profile and Clinical Manifestations in SCA Children
da Guarda, C. C., Yahouédéhou, S. C. M. A., Santiago, R. P., Fernandes, C. F. D. L., Neres, J. S. D. S., Oliveira, A. M. D. J., Aleluia, M. M., Figueiredo, C. V. B., Fonseca, C. A., Fiuza, L. M., et al. (2020) · Disease Markers · doi:10.1155/2020/8842362 · Cited by 14
“Albumin levels are thought to be increased in SCA individuals when compared to individuals with HbAS or HbAA genotype [32] and may be higher during hospitalization [33].”
BackgroundMombo, L., Mabioko-Mbembo, G., Bisseyé, C., Mbacky, K., Thiam, F., & Edou, A. (2019) · Nigerian Postgraduate Medical Journal · doi:10.4103/npmj.npmj_182_18 · Cited by 11
Efobi, C. C., Nri-Ezedi, C. A., Madu, C., Ikediashi, C. C., Ejiofor, O. S., & Ofiaeli, C. I. (2023) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v33i5.12 · Cited by 12
Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia
Qadah, T., Noorwali, A. A., Alzahrani, F. S., Banjar, A. S., Filimban, N., & Felimban, R. I. (2020) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-020-01270-3 · Cited by 9
Haematological indices of sickle cell patients with chronic leg ulcers on compression therapy
Babalola, O. A., Ogunkeyede, A., Odetunde, A., Fasola, F. A., Oni, A. A., Babalola, C. P., & Falusi, A. G. (2020) · African Journal of Laboratory Medicine · doi:10.4102/ajlm.v9i1.1037 · Cited by 9
Klouda, T. M., Raybagkar, D. A., Bernstein, B. A., & Apollonsky, N. (2020) · Advances in Hematology · doi:10.1155/2020/3656717 · Cited by 9
Jit, B. P., Mohanty, P. K., Pradhan, A., Purohit, P., Das, K., Patel, S., Meher, S., Sinha, S., Mohanty, J. R., Behera, R. K., et al. (2019) · Hemoglobin · doi:10.1080/03630269.2019.1623248 · Cited by 7
The Role of Platelets in Sickle Cell Disease
Brzóska, T., Kato, G. J., & Sundd, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00031-x · Cited by 8
Musa, A., & Ndakotsu, M. (2023) · Iraqi Journal of Hematology · doi:10.4103/ijh.ijh_24_23 · Cited by 5
Moeen, S. M., Thabet, A. F., Hasan, H. A., & Saleh, M. A. (2017) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-017-0814-z · Cited by 5
“The risk is higher in patients with low baseline hemoglobin, low fetal hemoglobin, high white blood cell count, Hb SS disease and could be candidates for early and aggressive therapy with disease modifying agents [16].”
BackgroundAbdulla, M., Almoosa, F. J., Moosa, R. J. A., & AlQamish, J. (2017) · International Journal of General Medicine · doi:10.2147/ijgm.s139833 · Cited by 6
“The patients had increased bilirubin and albumin levels and WBC count, as had been established in the earlier studies.(1,5,17,18) The liver function tests also showed typically abnormal results, with ALT and GGT outside the normal ranges.”
Yurtsever, N., Tong, N., Geetha, S. D., Nandi, V., & Shi, P. A. (2024) · Transfusion · doi:10.1111/trf.18044 · Cited by 4
“18 Most recently, a study of 24 patients with SCD on chronic RCE found that post-procedure Hct did not influence the post-procedure rate of rise in HbS. 19 26 These associations make sense given the contribution of leukocytosis and neutrophilia to vaso-occlusion.”
Ugwu, N. I., Okike, C. O., Ugwu, C. N., Ezeonu, C. T., Iyare, F., & Alo, C. N. (2021) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_178_20 · Cited by 3
Bhaskar, L. V., & Pattnaik, S. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00915 · Cited by 3
A study of hepatobiliary involvement in adult patients with sickle cell disease
Mohanty, A. P., Yellapu, V., Kumar, K. M., Saxena, A., & Deo, D. S. (2020) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20203599 · Cited by 2
Lad, H., Naskar, S., Pasupuleti, S. K. D. B. P., Nahrel, R., Sihare, P., Chandak, G. R., & Patra, P. K. (2022) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2022.2126042 · Cited by 2
Evaluation of Serum Zinc Level among Yemeni Patients with Sickle Cell Anemia
Al-Jamali, B. A. A. K., Salem, A. K., Hajar, M. A., & Al-Shamahy, H. A. (2025) · مجلة جامعة صنعاء للطب والعلوم الصحية · doi:10.59628/jchm.v19i2.1638 · Cited by 2
“This finding aligns with previous studies that also reported elevated total white cell counts in individuals with SCA [22, 36, 37].”
The Impact of Bone Pain Crises on Platelet Parameters in Sample of Iraqi Sickle Cell Anemia Patients
Al‐Saidi, D. N. (2024) · Journal of Applied Hematology · doi:10.4103/joah.joah_11_24 · Cited by 1
Ouali, F., Sahli, A., Amri, Y., Dabboubi, R., Fredj, S. H., Othmani, M., Chelbi, S., Salem, L. B., Ghazouani, E., & Messaoud, T. B. (2026) · Hemoglobin · doi:10.1080/03630269.2026.2655317 · Cited by 1
“It was found that a high level of leucocytes was associated with frequent hospital admission [17], frequent emergency department visits [18] and with more complications [19] especially ACS [20,21] and stroke [22].”
Le, G., Dillon, A., Smith, O. P., & McMahon, C. (2026) · British Journal of Haematology · doi:10.1111/bjh.70579 · Cited by 1
Review on Pathology of Blood and Urine
Pawar, S. S., Bais, S. K., & Mane, R. P. (2023) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-8082 · Cited by 1
Mathavan, A., Mathavan, A., Mathavan, M., Krekora, U., Winer, A. J., Altshuler, E., Wnek, R. D., Hones, K. M., Thaper, A., Artola, R., et al. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2231637 · Cited by 1
“kocytosis which, in addition to higher steady-state platelet counts or lower steady-state hemoglobin values, has been associated with a greater incidence of emergency room use [15].”
BackgroundAsafa, M. A., Ahmed, I. O., Umar, A. S., Bolarinwa, R. A., & Ogunlade, O. (2023) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_31_23 · Cited by 1
Allen, E. K., Penkert, R. R., Hankins, J. S., Surman, S. L., de Velde, L.-A. V., Cotton, A., Hayden, R. T., Tang, L., Yuan, X., Zheng, Y., et al. (2024) · Vaccines · doi:10.3390/vaccines12090984 · Cited by 2
Desai, A., Desai, K., Desai, H. A., Desai, R. A., Desai, C., & Purohit, P. (2023) · Indian Journal of Pharmacy Practice · doi:10.5530/ijopp.16.2.25
Asafa, M. A., Ahmed, I. O., Agim, M. B., Fabinu, T. A., Kusoro, S. O., Ogunoye, B. T., Ogunlade, O., & Bolarinwa, R. A. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07303-2
“Significantly higher WBC and platelet in sickle cell disease have been implicated as a major risk factor for stroke and other sickle cell complications [29].”
Emergency department utilization patterns in adults living with sickle cell disease
Rech, J., Santin, A., Lionnet, F., Mattioni, S., Dubreucq, E., Steichen, O., & Boëlle, P. (2025) · British Journal of Haematology · doi:10.1111/bjh.70190
“5,26,28,29 However, all these studies were conducted in high-income countries, where ED access is relatively easy.”
Ssekandi, A. M., Namazzi, R., Muwonge, H., Kalysebula, R., Munabi, I. G., Sekaggya‐Wiltshire, C., Namaganda, A., Kimuli, P. I., Akugizibwe, R., Kasujja, H., et al. (2026) · medRxiv · doi:10.64898/2026.01.15.26344176
Akubuo, C. R.-M., Okorocha, B. O., Chinelo, O. J., Arinze, A. K., Chigemezu, O. D., Akandu, E. G., & Ifeanyichukwu, O. P. (2026) · World Scientific News · doi:10.65770/iaxi9244
Ssekandi, A. M., Namazzi, R., Muwonge, H., Kalyesubula, R., Munabi, I. G., Sekaggya‐Wiltshire, C., Namaganda, A., Kimuli, I., Akugizibwe, R., Kasujja, H., et al. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005898
“Curtis et al.’s study in adults showed that higher steady-state leukocyte and platelet counts were associated with frequent emergency care utilization, underscoring that persistent inflammation and platelet activation may track with disease severity and health-care burden [21].”
Introduction of high-dimensional interpretable machine learning models and their applications
Bussy, S. (2019) · theses.fr (ABES) · doi:10.70675/20562d5fzaef6z421aza27cza1137406e629
Spirometry Patterns in Adult Sickle Cell Disease: A Retrospective Observational Study
Almusally, R. M., Alghamdi, R., Almubarak, M., Ibrahim, M., Alyousif, H., AlElq, Z., Alwaheed, A., Sultan, O. A., Saeed, A. A., Qutub, H. O., et al. (2026) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_490_25
Blood Transfusion and ABO Blood Groups in Sickle Cell Disease
Alsalman, M., Sahlawi, M. A. A., Abid, N., Elzorkany, K. M. A., Abdallah, E., Alquraini, A. M., Alkhalifa, H. A., Shafey, M. M., & Alsalman, Z. (2026) · Medicina · doi:10.3390/medicina62081449
“In addition, hematological parameters such as hemoglobin level, white blood cell count (WBC), and platelet count have been strongly associated with SCD-related complications, including ACS and VOC, both of which are considered important indicators of more severe disease progression [9,20].”
Metadata
- Authors
- Curtis, S. A., Danda, N., Etzion, Z., Cohen, H. W., & Billett, H. H.
- Affiliations
- Montefiore Medical Center (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Curtis, Susanna A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-06
- Volume
- 10
- Issue
- 8
- Pages
- e0133116
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4527736
- OpenAlex
- W2278941491
- Cited by
- 53
- References
- 28
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 10 · 2019: 7 · 2018: 2 · 2017: 7 · 2016: 1
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Georgia Clinical and Translational Science Alliance (UL1 RR025750, TL1RR025748, KL2RR025749)
- National Institutes of Health (UL1TR001073)
- National Center for Research Resources (RR-025750, UL1RR025750, KL2RR025749, RR025748, RR025749, TL1RR025748)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Emergency Medicine › Emergency and Acute Care Studies
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, emergency department utilization, white blood cell count, platelet count, hemoglobin levels, hydroxyurea, disease-modifying agents, health care utilization, fetal hemoglobin, lactate dehydrogenase, reticulocyte count
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anemia, Sickle Cell, Blood Platelets, Demography, Emergency Service, Hospital, Female, Fetal Hemoglobin, Humans, Hydroxyurea, L-Lactate Dehydrogenase, Leukocyte Count, Leukocytes, Male, Middle Aged, Platelet Count, Risk, Odds Ratio, Reticulocyte Count, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.